Kiniksa Pharmaceuticals KNSA reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Kiniksa Pharmaceuticals beat estimated earnings by 12.2%, reporting an EPS of $-0.36 versus an estimate of $-0.41.
Revenue was up $32.19 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 5.93% drop in the share price the next day.
Here's a look at Kiniksa Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.42 | -0.65 | -0.79 | -0.80 |
| EPS Actual | -0.53 | -0.44 | -0.61 | -0.72 |
| Revenue Estimate | 20.72M | 10.18M | 3.97M | 3.72M |
| Revenue Actual | 18.75M | 12.10M | 7.70M | 0 |
To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
